Dickson Adah

An update on the regulatory mechanisms of NLRP3 inflammasome activation

Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection

Neuroprotective Effect of Scutellarin on Ischemic Cerebral Injury by Down-Regulating the Expression of Angiotensin-Converting Enzyme and AT1 Receptor

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection

Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs

Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements

Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome

Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective

Inflammation in obesity, diabetes, and related disorders

Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection

Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development

Recent Advances in Therapeutic Genome Editing in China

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy

Scutellarin and caffeic acid ester fraction, active components of Dengzhanxixin injection, upregulate neurotrophins synthesis and release in hypoxia/reoxygenation rat astrocytes

The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages

Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection